The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant pembrolizumab (PEMBRO) and axitinib (AXI) in renal cell carcinoma with associated inferior vena cava tumor thrombus (NEOPAX).
 
Stephanie Lakritz
No Relationships to Disclose
 
Nellowe Candelario
No Relationships to Disclose
 
Andrew Nicklawsky
No Relationships to Disclose
 
Simon P. Kim
No Relationships to Disclose
 
Elizabeth R. Kessler
Speakers' Bureau - Targeted Oncology
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck Serono (Inst); Pfizer (Inst)